Keyphrases
Retrospective Review
100%
Infusion Reaction
100%
Natural Killer Cell Immunotherapy
100%
Natural Killer Cells
81%
Cell Infusion
54%
Confidence Interval
36%
Odds Ratio
36%
Cardiovascular Reactivity
27%
Hypertension
18%
Monocytes
18%
Non-associated
9%
Interleukin-2
9%
Retrospective Chart Review
9%
Life-threatening
9%
Close Monitoring
9%
Incubation Time
9%
Headache
9%
Hematological Malignancies
9%
Cell Dose
9%
Variables of Interest
9%
Overall Response Rate
9%
Multivariable Logistic Regression
9%
Patient Experience
9%
Logistic Regression Model
9%
Storage Time
9%
Cellular Immunotherapy
9%
Clinical Protocols
9%
Reaction Types
9%
Adoptive Cell Therapy
9%
Natural Killer Cell Therapy
9%
Common Terminology Criteria for Adverse Events (CTCAE)
9%
Therapy Experiences
9%
Medicine and Dentistry
Natural Killer Cell
100%
Infusion
100%
Immunotherapy
100%
Odds Ratio
23%
Cardiovascular System
23%
Symptom
17%
Monocyte
11%
Cell Therapy
11%
In Vitro
5%
T Cell
5%
Incubation
5%
Adverse Event
5%
Logistic Regression Analysis
5%
Headache
5%
Hematologic Malignancy
5%
Chill
5%
Patient Experience
5%
Nursing and Health Professions
Infusion
100%
Immunotherapy
100%
Odds Ratio
23%
Confidence Interval
23%
Symptom
17%
Cell Therapy
11%
Adverse Event
5%
Logistic Regression Analysis
5%
Hematologic Malignancy
5%
Clinical Protocol
5%
Headache
5%
Chill
5%
Nomenclature
5%